HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
Recruiting now
Conditions studied: Menopausal Syndrome
In brief
Therefore, the aim of this study is to assess the therapeutic effect on overactive bladder symptoms, sexual function, heart rate variability, arterial stiffness, atherosclerosis, sleep, and depression between tibolone and E2V/MPA. From the results, the investigators will compare the effect of tibolone versus E2V/MPA on overactive bladder symptoms, sexual function, autonomic function, arterial stiffness, atherosclerosis, sleep and depression.
Key facts
- Study ID
- NCT05280028
- Run by
- Far Eastern Memorial Hospital
- People needed
- 100
- Starts
- 2022-02-07
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2024-06-17
Who can join
Age: 20 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- >20 years old female
- Menopausal symptoms, still have a uterus, and no breast or other cancers, and no vascular-blocking disease such as stroke.
You may not qualify if…
- Nil.
Where it is running
- Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital — Banqiao District, New Taipei, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.